Caprock Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,039
Closed -$384K 430
2018
Q3
$384K Sell
4,039
-93
-2% -$7.93K 0.08% 214
2018
Q2
$319K Buy
4,132
+114
+3% +$8.55K 0.07% 269
2018
Q1
$278K Buy
4,018
+16
+0.4% +$1.22K 0.06% 294
2017
Q4
$324K Sell
4,002
-111
-3% -$7.1K 0.06% 275
2017
Q3
$260K Buy
4,113
+438
+12% +$27.2K 0.05% 330
2017
Q2
$235K Buy
3,675
+33
+0.9% +$2.07K 0.05% 339
2017
Q1
$240K Sell
3,642
-411
-10% -$28.3K 0.06% 291
2016
Q4
$279K Sell
4,053
-2,744
-40% -$197K 0.07% 243
2016
Q3
$479K Sell
6,797
-33
-0.5% -$2.47K 0.11% 173
2016
Q2
$518K Sell
6,830
-211
-3% -$15.5K 0.13% 154
2016
Q1
$484K Buy
+7,041
New +$506K 0.11% 162

Other funds holding ESRX

Caprock Group's ESRX Position: Q4 2018 in Review

Caprock Group sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,039 shares — an estimated $384K sold.

Caprock Group first reported a position in ESRX in Q1 2016 and held it in 11 quarters. The position peaked at $518K in Q2 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Caprock Group reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Caprock Group sold 4,039 Express Scripts Holding Company shares in Q4 2018, an estimated $384K.
  • Caprock Group first reported a position in Express Scripts Holding Company in Q1 2016 and held it in 11 quarters.
  • Caprock Group's Express Scripts Holding Company position peaked at $518K in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Caprock Group's 13F filing for Q4 2018, filed 29 Jan 2019.